Logo image of LXEO

LEXEO THERAPEUTICS INC (LXEO) Stock Analyst Earnings Estimates

NASDAQ:LXEO - Nasdaq - US52886X1072 - Common Stock - Currency: USD

3.89  -0.14 (-3.47%)

After market: 3.89 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LXEO revenue by date.LXEO revenue by date.
520K1.66M
219.23%		650K
-60.84%
-100.00%		655.717K
-100.00%		29.07M163.71M
463.16%		394.02M
140.68%		705.46M
79.04%		1.883B
166.92%		2.619B
39.09%
EBITDA
YoY % growth
LXEO ebitda by date.LXEO ebitda by date.
-4.59M-50.63M
-1,003.05%		-60.24M
-18.98%		-73.44M
-12.78%		-102M
-50.14%		-80.58M
21.00%		-81.6M
-1.27%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
LXEO ebit by date.LXEO ebit by date.
-4.59M-50.64M
-1,003.27%		-60.51M
-19.49%		-72.634M
-13.23%		-109.29M
-59.52%		-117.402M
-7.42%		-121.574M
-3.55%		-243.78M
-100.52%		-163.2M
33.05%		44.88M
127.50%		417.18M
829.55%		913.92M
119.07%		1.506B
64.78%
Operating Margin
LXEO operating margin by date.LXEO operating margin by date.
-882.69%-3,050.60%-9,309.23%N/AN/A-17,904.40%N/A-838.60%-99.69%11.39%59.14%48.54%57.50%
EPS
YoY % growth
LXEO eps by date.LXEO eps by date.
N/AN/AN/A-4.12-3.18
22.84%		-3.07
3.57%		-3.18
-3.79%		-3.63
-14.01%		-2.87
21.07%		1.00
134.88%		7.91
690.82%		17.13
116.65%		27.54
60.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.82
3.14%		-0.81
-5.31%		-0.83
-29.09%		-0.82
8.03%		-0.84
-1.59%		-1.00
-23.27%		-1.04
-25.93%		-1.08
-32.09%		-1.04
-24.39%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-22.44M
-55.87%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-29.412M
-96.42%		-33.443M
-43.59%		-34.308M
-45.68%		-35.333M
-43.88%		-36.392M
-23.73%		-40.653M
-21.56%		-42.339M
-23.41%		-44.106M
-24.83%		-45.957M
-26.28%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.89
92.80%		-0.69-0.20-28.59%
Q2 2024
Q2Q % growth		 -0.64 -0.710.079.25%
Q1 2024
Q2Q % growth		 -0.77 -0.780.011.64%
Q4 2023
Q2Q % growth		 -0.85 -0.74-0.11-14.55%
Q3 2023
Q2Q % growth		 -12.36 -2.65-9.71-366.42%
LXEO Yearly EPS VS EstimatesLXEO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth
-100.00%		%
Q1 2023
Q2Q % growth
-100.00%		%
LXEO Yearly Revenue VS EstimatesLXEO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% -12.81%
RevenueN/A N/A N/A N/A